Company Filing History:
Years Active: 2011
Title: Dubravko Jelic: Innovator in Anti-Inflammatory Macrolides
Introduction
Dubravko Jelic is a notable inventor based in Samobor, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolides with anti-inflammatory properties. His work is essential in addressing various inflammatory diseases and conditions.
Latest Patents
Jelic holds a patent for "Macrolides with anti-inflammatory activity." This invention pertains to novel semi-synthetic macrolides that exhibit anti-inflammatory effects. Specifically, it focuses on 14- and 15-membered macrolides substituted at the 4″ position, along with their pharmaceutically acceptable derivatives. The patent also covers processes and intermediates for their preparation, as well as pharmaceutical compositions containing these compounds. The invention is particularly relevant for treating inflammatory diseases associated with excessive secretion of TNF-α, IL-1, IL-8, IL-2, or IL-5, and for inhibiting excessive lymphocyte proliferation and granulocyte degranulation. Jelic has 1 patent to his name.
Career Highlights
Dubravko Jelic is currently associated with Glaxo Group Limited, a prominent player in the pharmaceutical industry. His work at Glaxo has allowed him to focus on innovative solutions for health challenges, particularly in the realm of inflammation.
Collaborations
Throughout his career, Jelic has collaborated with esteemed colleagues such as Sulejman Alihodzic and Martina Bosnar. These collaborations have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Dubravko Jelic's contributions to the field of anti-inflammatory macrolides highlight his innovative spirit and dedication to improving health outcomes. His patent and ongoing work at Glaxo Group Limited underscore the importance of research in combating inflammatory diseases.